Impact of Lactation Antenatal Teaching by Clinicians and Healthcare Providers (iLATCH)
Impact of Lactation Antenatal Teaching by Clinicians and Healthcare Providers: Randomized Control Trial
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Elaine Hart, M.D.
- Telefonnummer: 15505 (909) 558-2806
- E-mail: ehart@llu.edu
Studiesteder
-
-
California
-
Loma Linda, California, Forenede Stater, 92354-3619
- Rekruttering
- Loma Linda University Faculty Medical Offices
-
Kontakt:
- Elaine Hart, M.D.
- Telefonnummer: 15505 909-558-2806
- E-mail: ehart@llu.edu
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Nulliparous mothers
- Multiparous mothers who did not breastfeed previous children or breastfed previous children for less than 6 months
Exclusion Criteria:
- Mothers planning to use formula
- Multiparous mothers who previously breastfed for more than 6 months
- Mothers with HIV
- Mothers with a history of breast reduction surgery
- Infants with major birth defects that may impede growth or feeding, such as cleft lip and/or palate, cardiac defects, and gastrointestinal defects
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Breastfeeding Education
Participants receive 3 prenatal breastfeeding education interventions during antenatal visits.
6-week postpartum survey will be administered.
|
First meeting will include a pre-test and will go over risks, benefits, and goals for breastfeeding for the mother, baby and family.
Second meeting will go over barriers to breastfeeding and the difference between formula and breastmilk.
Third visit will include a post-test and go over misconceptions of breastfeeding and the optimal frequency to breastfeed their newborn.
Appropriate flyers will be administered at each visit.
Congratulatory & supportive text at birth and 6-week follow up survey will also be administered.
|
|
Ingen indgriben: Placebo
Participants receive no extra breastfeeding education during antenatal visits.
6-week postpartum survey will be administered.
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Prevalence of Exclusive Breastfeeding at 6 Weeks Postpartum.
Tidsramme: Change between baseline (time of newborn's first feeding) and 6 week post-partum visit.
|
Subjects will complete a Qualtrics survey of 2 questions administered via text message, to determine breastfeeding exclusivity.
This survey will be calculated on a Likert scale 0-100.
A percentage of 100% will determine exclusive breastfeeding.
A percentage of 70-90% represents intermittent breastfeeding.
A percentage of less than 70% represents non-exclusive breastfeeding.
|
Change between baseline (time of newborn's first feeding) and 6 week post-partum visit.
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Breastfeeding education pre and post self-efficacy scores of medical students
Tidsramme: Change between baseline through study completion, an average of 1 year.
|
Assessment of medical student proficiency in breastfeeding management and patient care will be measured using a 25-item multiple-choice questionnaire.
The survey evaluates core competencies before and after a structured educational intervention, including the Institute for the Advancement of Breastfeeding and Lactation Education (IABLE) course and a supplemental PowerPoint presentation given by Dr. Elaine Hart.
Each question is worth one point, with total scores ranging from 0 to 25; a higher score indicates an increase in breastfeeding knowledge and management competency.
|
Change between baseline through study completion, an average of 1 year.
|
|
Maternal Satisfaction with Antenatal Breastfeeding Support and Knowledge, Motivation, and Confidence.
Tidsramme: Change between 1st trimester and 6 weeks postpartum.
|
Assessment of maternal satisfaction with antenatal breastfeeding support, knowledge, motivation, and confidence will be measured using a 13-item questionnaire.
The instrument utilizes a combination of 5-point Likert scales to assess self-efficacy and motivation, as well as objective multiple-choice questions to evaluate understanding of breastfeeding benefits, infant output, and clinical management.
Knowledge-based items are scored with one point for each correct response, while Likert-scale items are recorded by their selected numerical value (1-5).
A higher total composite score represents a longitudinal increase in breastfeeding knowledge, confidence, and motivation from baseline (pre-enrollment) to the 6-week postpartum follow-up.
|
Change between 1st trimester and 6 weeks postpartum.
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 5260056
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .